- Price is above the Trend Line, keeping the weekly tape constructive.
6810
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Bio Preventive Medicine Corp. · Healthcare · Biotechnology
Latest close
23.05 TWD
9.8%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is 1.1% above the Trend Line and sits at 22.2% of its 52-week range. The latest completed week returned 9.8%, after a -4.4% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
17
out of 100
Latest Close
23.05 TWD
14 Aug 2026
1W Return
9.8%
latest completed week
4W Return
-4.4%
short-term follow-through
12W Return
-24.9%
quarterly tape
Trend Breadth
17.3%
9 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 36.01% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
9.8%
Latest completed week; four-week move -4.4%.
Indicator stack
10/5
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.01%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.1% above the Trend Line and sits at 22.2% of its 52-week range. The latest completed week returned 9.8%, after a -4.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4112-week average 0.53
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.4% over four weeks, -24.9% over 12 weeks, and -14.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.78Latest activity-pressure read.
Pressure change-391.6%Four-week change in activity pressure.
Leadership-29.42Latest relative-leadership reading.
RS change-11.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-49.9%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher9 of 2616 weeks finished lower.
Best week+94.9%Week of 24 Apr.
Worst week-15.4%Week of 1 May.
Latest week+9.8%Week of 14 Aug.
Shape of recent returns
Strong gains5
Modest gains4
Flat weeks1
Modest losses8
Sharp losses8
Recent vol7.7%13-week weekly-return volatility.
Base vol14.2%52-week weekly-return volatility.
Up/down split18/32Count of positive and negative weeks in the 52-week window.
Average skew8.6% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank- / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank60 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape16/100
Trend, activity pressure, participation, and risk combine to a 16/100 tape read.
Indicator analysis45/100Latest 12-week confirmation: trend 8/12, activity pressure 7/12, relative leadership 0/12.
Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 36.01%Next-week expectancy is negative with a 36.01% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 23.05 TWD | 9.8% | 22.80 TWD | 30.31 TWD | -0.78 | -29.42 | 317.5K | Off |
| 7 Aug 2026 | 21.00 TWD | -2.6% | 22.72 TWD | 30.40 TWD | -0.67 | -34.50 | 294.5K | Off |
| 31 Jul 2026 | 21.55 TWD | -4.6% | 22.78 TWD | 30.51 TWD | -0.55 | -32.40 | 346.2K | Off |
| 24 Jul 2026 | 22.60 TWD | -6.2% | 22.80 TWD | 30.61 TWD | -0.35 | -31.26 | 192.2K | Off |
| 17 Jul 2026 | 24.10 TWD | 12.6% | 22.80 TWD | 30.71 TWD | -0.16 | -26.37 | 1.5M | On |
| 10 Jul 2026 | 21.40 TWD | 0.0% | 22.75 TWD | 30.79 TWD | 0.01 | -39.62 | 241.1K | On |
| 3 Jul 2026 | 21.40 TWD | -9.1% | 22.81 TWD | 30.91 TWD | 0.26 | -42.67 | 584.5K | On |
| 26 Jun 2026 | 23.55 TWD | -14.7% | 22.86 TWD | 31.02 TWD | 0.51 | -35.15 | 726.8K | On |
| 19 Jun 2026 | 27.60 TWD | 0.5% | 22.83 TWD | 31.11 TWD | 0.67 | -28.53 | 221.9K | On |
| 12 Jun 2026 | 27.45 TWD | -8.7% | 22.71 TWD | 31.18 TWD | 0.80 | -26.55 | 748.2K | On |
| 5 Jun 2026 | 30.05 TWD | -0.2% | 22.61 TWD | 31.25 TWD | 0.87 | -22.55 | 1.1M | On |
| 29 May 2026 | 30.10 TWD | -2.0% | 22.38 TWD | 31.30 TWD | 0.94 | -23.19 | 1.1M | On |
| 22 May 2026 | 30.70 TWD | 9.3% | 22.18 TWD | 31.36 TWD | 1.01 | -18.48 | 2.1M | On |
| 15 May 2026 | 28.10 TWD | 7.3% | 21.97 TWD | 31.41 TWD | 1.04 | -23.97 | 936.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.